Pre-Chronic Care Programs
Resolute Imaging concentrates on detecting and identifying pre-chronic disorders, while they can still be reversed. Our solution uses artificial intelligence (AI) and deep learning algorithms to read the signatures of early abdominal disease.
Our patented, FDA-cleared AI-Imaging™ Solution improves patient outcomes through early identification of pre-chronic conditions, provides guidance toward appropriate care programs, and monitors progress to holistic wellness.
Significantly Improving Detection And Monitoring Of
Reversible Abdominal Diseases
At Resolute Imaging, we took a novel approach to abdominal wellness by developing a low-cost, FDA-cleared diagnostic tool that finds early indications of significant diseases BEFORE they manifest into chronic conditions. We call this Pre-Chronic Care and it is the core of what we do.
Most vendors identify chronic conditions so providers and payers can manage treatment and contain costs as these irreversible conditions progress to cancer or organ failure. With AI-Imaging™, we have clinically proven early detection of pre-chronic conditions so providers can treat patients to prevent or reverse terminable disease.
Clinical Trial Results
Standard of Care
Standard of Care
Reversible vs Chronic
Resolute Imaging uncovered 92% positive findings with diagnostic concerns, while only 15% had positive findings using today’s Standard of Care.
Our innovative solutions are designed to achieve exceptional clinical results, making it possible to detect, diagnose and treat reversible and chronic disease earlier and more effectively.
Closing Gaps in Care
One of the best ways to maximize profit is to minimize cost and for health insurance companies, that means closing gaps in care. Members with modifiable health risks not only have poorer health outcomes, but also account for a substantial amount of long-term healthcare spending. Healthy members, on the other hand, have better outcomes and do not have substantial healthcare spending because they are less likely to accrue large medical bills.
Year One of Our
Patented, FDA-Cleared AI-Imaging™ Solution Could Save You Millions
Our latest study shows significant improvement in finding reversible diseases is achieved by using Resolute's Imaging Program and its patented, FDA-Cleared AI-Imaging™ Solution.
If you treat a population of 10,000 members, based on national prevalence, you have 8746 members with diseases ranging from fatty liver disease (FLD) to cancer. Significant cost can be avoided if members can stop disease progression in the initial stage.
PRE-CHRONIC CARE COST
Some patients diagnosed with multiple diseases.